
|Articles|June 24, 2021
The Mainstream Patient: June 24, 2021
Author(s)Morgan Petronelli
This week’s edition of The Mainstream Patient features stories about face mapping, benzene contamination in sunscreen, natural retinol, ceramides in skin care, plus more.
Advertisement
In this week’s edition, Allure dives into the benzene contamination in sunscreen and after-sun care products controversy, and Hello Giggles explains what face mapping is. Plus, Shape provides an in-depth guide to Botox and reveals why ceramides are so popular in skin care right now. Finally, Harper's Bazaar dives into natural retinol and why plastic surgeons are now accepting cryptocurrency.
Advertisement
Related to this article

From “Botox in a bottle” to castor oil and face taping, Dermatology Times reviews the evidence behind 3 viral dermatology trends from October.

Dermatology PAs unpack 4 frightening skin care myths and trends, from sunscreen misinformation and citrus DIYs to overusing actives and beef tallow.

The approval expands the IL-23 inhibitor’s indications beyond moderate-to-severe plaque psoriasis to include adults with active psoriatic arthritis.

Find out what skin care products and aesthetic innovations clinicians are recommending to patients for the month of October.

Clinician FAQ on remibrutinib's FDA approval in symptomatic dermographism: RemIND efficacy, mechanism, safety, and supporting CSU evidence.

Elevate-Derm Summer 2026 faculty share practical lessons on hair loss exams, PIH, geriatric dermatology, and managing cholesterol rises on JAK inhibitors.

Atopic dermatitis care is evolving with flexible biologic dosing, expanded pediatric options, and novel oral, topical, and systemic therapies.
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Approves Tildrakizumab for Active Psoriatic Arthritis
2
The Scariest Skin Care Trends Haunting Patients This Halloween
3
October Social Media Mythbusters: 3 Viral Beauty Claims, Debunked
4
Improving Early Identification and Escalation of HS
5


